clinical trial · NCT04035200
Safety, Tolerability and Efficacy Study of V117957 in Subjects With Insomnia Associated With Alcohol Cessation
InsomniaV117957 tabletsPlacebo
brief summary
The purpose of this study is to evaluate the safety, tolerability and efficacy of V117957 in subjects with alcohol use disorder (AUD) who experience insomnia associated with alcohol cessation, compared to placebo.
started
Sep 23, 2019
primary completion
Nov 6, 2020
completion
Nov 6, 2020
last updated
Sep 18, 2023
official title
A Phase 2, Randomized, Double-Blind, Multi-Center, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety, Tolerability, and Efficacy of V117957 in Subjects With an Alcohol Use Disorder Who Are Experiencing Insomnia Associated With Alcohol Cessation
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol